Log In
BCIQ
Print this Print this
 

BBI-2000

  Manage Alerts
Collapse Summary General Information
Company Brickell Biotech Inc.
DescriptionAnti-inflammatory small peptide
Molecular Target
Mechanism of Action 
Therapeutic ModalityPeptide
Latest Stage of DevelopmentPreclinical
Standard IndicationDermatitis
Indication DetailsTreat contact dermatitis
Regulatory Designation
Partner

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
Total Number of DealsTotal Deal ValueTotal Upfront CashTotal Milestone Payments

1

0

0

0


 Deals Details
DateCompanies InvolvedDeal HeadlineTotal Deal ValueTotal Upfront CashTotal Milestone

03/04/2013

Undisclosed

Undisclosed

Undisclosed

Get a free BioCentury trial today